Citation: P. Periti et F. Tonelli, Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii, J CHEMOTHER, 13(5), 2001, pp. 473-493
Authors:
Mazzei, T
Novelli, A
Esposito, S
Fallani, S
Noviello, S
Cassetta, MI
Conti, S
Periti, P
Citation: T. Mazzei et al., Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients, J CHEMOTHER, 12(4), 2000, pp. 306-313
Citation: P. Periti et P. Nicoletti, Classification of betalactam antibiotics according to their pharmacodynamics, J CHEMOTHER, 11(5), 1999, pp. 323-330
Citation: P. Periti et T. Mazzei, Clarithromycin: Pharmacokinetic and pharmacodynamic interrelationships anddosage regimen, J CHEMOTHER, 11(1), 1999, pp. 11-27
Citation: P. Periti et al., Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery, EUR J CL M, 18(2), 1999, pp. 113-119
Citation: P. Periti et T. Mazzei, New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock, INT J ANT A, 12(2), 1999, pp. 97-105
Citation: P. Periti et T. Mazzei, Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review, J CHEMOTHER, 10(6), 1998, pp. 427-448
Citation: P. Periti et al., Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1998), J ANTIMICRO, 42(6), 1998, pp. 840-840
Citation: P. Periti et al., Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1988), J ANTIMICRO, 42(5), 1998, pp. 682-682